{"id":3697,"date":"2015-06-22T23:05:01","date_gmt":"2015-06-22T23:05:01","guid":{"rendered":"http:\/\/opentextbc.ca\/clinicalskills\/?post_type=chapter&#038;p=3697"},"modified":"2021-05-20T22:04:23","modified_gmt":"2021-05-20T22:04:23","slug":"blood-and-blood-product-administration","status":"publish","type":"chapter","link":"https:\/\/opentextbc.ca\/clinicalskills\/chapter\/blood-and-blood-product-administration\/","title":{"raw":"8.7 Transfusion of Blood and Blood Products","rendered":"8.7 Transfusion of Blood and Blood Products"},"content":{"raw":"All health care practitioners who administer blood or blood products must complete specific training for safe transfusion practices and be competent in the transfusion administration process. Always refer to your agency policy for guidelines for preparing, initiating, and monitoring blood and blood product transfusions. These guidelines apply to adult patients only.\r\n\r\nThe transfusion of blood or blood products (see Figure 8.8) is the administration of whole blood, its components, or plasma-derived products. The primary indication for a red blood cell (RBC) transfusion is to improve the oxygen-carrying capacity of the blood (Canadian Blood Services, 2013). A health care provider order is required for the transfusion of blood or blood products. RBC transfusions are indicated in patients with anemia who have evidence of impaired oxygen delivery. For example, individuals with acute blood loss, chronic anemia and cardiopulmonary compromise, or disease or medication effects associated with bone marrow suppression may be candidates for RBC transfusion. In patients with acute blood loss, volume replacement is often more critical than the composition of the replacing fluids (Canadian Blood Services, 2013). Transfusions can restore blood volume, restore oxygen-carrying capacity of blood with red blood cells, and provide platelets and clotting factors. The most common type of blood transfusion is blood that is donated by another person (allogeneic). Autologous transfusion is the transfusion of one's own blood (Perry et al., 2014).\r\n\r\n[caption id=\"attachment_5795\" align=\"aligncenter\" width=\"199\"]<a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_1204-e1443928446983.jpg\"><img class=\"wp-image-5795 size-medium\" src=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_1204-e1443928446983-199x300.jpg\" alt=\"Red Blood Cells and Blood IV tubing\" width=\"199\" height=\"300\" \/><\/a> Figure 8.8 Red blood cells and blood IV tubing[\/caption]\r\n\r\nTransfusion therapy is considered safe, and stringent precautions are followed in the collection, processing, and administration of blood and blood components. However, transfusions still carry risks such as incompatibility, human error, and disease transmission, and\u00a0blood transfusion must be taken seriously at all times. Incompatibility can be decreased by using irradiated red blood cells or leukocyte-reduced blood. The majority of blood transfusion complications are a result of human error (Perry et al., 2014).\r\n\r\nCompatibility testing is vital for all recipients of blood or blood products. Recipients must be transfused with an ABO group specific to their own blood type or ABO group-compatible. There are three types of blood typing systems:\u00a0ABO, Rh, and human leukocyte antigen (HLA). For more information on these, refer to the online resources at the end of this chapter. It is vital to understand what types of blood groups are compatible for transfusions (Canadian Blood Services, 2013).\r\n\r\nWhen administering blood and blood products, it is important to know the patient's values and beliefs regarding blood products. Some groups of individuals, mainly Jehovah Witnesses, will refuse blood transfusions or blood products based on religious beliefs. These individuals will refuse transfusion of whole blood and primary blood components but may accept transfusion of derivatives of primary blood components such as albumins solutions, clotting factors and immunoglobulins. Always assess each individual preference to establish if a blood component is an acceptable treatment to manage their illness or condition (Canadian Blood Services, 2007).\r\n\r\nWhen managing blood transfusions, it is important to prevent complications from occurring and to identify issues promptly to manage reactions effectively. Transfusion reactions (mild to life-threatening) may occur despite all safety measures taken. All transfusion reactions and transfusion errors must be reported to the hospital's transfusion services (blood bank). It is imperative to know what signs and symptoms to look for, and to educate your patient on what to report and when to report potential transfusion reactions. Mild to severe reactions may include (Canadian Blood Services, 2011):\r\n<ul>\r\n \t<li>Temperature \u2265 38.0 C or change of 1\u00b0C from pretransfusion value within 15 minutes after initiation of transfusion<\/li>\r\n \t<li>Acute or delayed hemolytic transfusion reaction<\/li>\r\n \t<li>Hypotension\/shock<\/li>\r\n \t<li>Rigors<\/li>\r\n \t<li>Anxiety<\/li>\r\n \t<li>Back or chest pain<\/li>\r\n \t<li>Nausea\/vomiting<\/li>\r\n \t<li>Shortness of breath (dyspnea)<\/li>\r\n \t<li>Hemoglobinuria<\/li>\r\n \t<li>Bleeding\/pain at IV site<\/li>\r\n \t<li>Tachycardia\/arrhythmia<\/li>\r\n \t<li>Generalized flushing<\/li>\r\n \t<li>Rash \u2265 25% of body<\/li>\r\n \t<li>Urticaria and other anaphylaxis reactions<\/li>\r\n \t<li>Hemolysis after transfusion<\/li>\r\n \t<li>Cytopenias after transfusion<\/li>\r\n \t<li>Virus, parasite, and prion infections<\/li>\r\n \t<li>Non-immunological reactions including infection<\/li>\r\n \t<li>Circulatory overload<\/li>\r\n \t<li>Hypothermia<\/li>\r\n<\/ul>\r\nFor more information on types of reactions, signs and symptoms, and treatments, review the article <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4260299\/\" target=\"_blank\" rel=\"noopener noreferrer\">adverse events related to blood transfusions<\/a>, or see the online resources at the end of this chapter.\u00a0If patient has a blood transfusion reaction, always follow agency policy to manage mild to severe blood reactions. In general, if a reaction occurs, follow the steps outlined in Checklist 73.\r\n<table style=\"border-color: #000000; width: 100%;\" border=\"1px solid rgb(0, 0, 0)\"><caption><a id=\"checklist73\"><\/a>Checklist 73: Managing a Blood or Blood Product Transfusion Reaction<\/caption>\r\n<tbody>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 75px; text-align: center;\" colspan=\"5\">\r\n<h5 style=\"text-align: center;\"><span style=\"color: #000000;\">Disclaimer:\u00a0Always review and follow your hospital policy regarding this specific skill.<\/span><\/h5>\r\n<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 75px;\" colspan=\"5\">\r\n<h5><span style=\"color: #333333;\">Safety considerations:<\/span><em><span style=\"color: #333333;\">\u00a0<\/span><\/em><\/h5>\r\n<ul>\r\n \t<li>Always review your agency's algorithm for managing mild to severe reactions. If a reaction is mild (e.g., fever), and without any other complications, a patient may continue the transfusion if monitored closely. Most other transfusion reactions require the transfusion to be stopped immediately.<\/li>\r\n \t<li>A blood transfusion reaction may occur 24 to 48 hours post-transfusion.<\/li>\r\n \t<li>Each separate unit presents a potential for an adverse reaction.<\/li>\r\n \t<li>Follow emergency transfusion guidelines when dealing with an emergency blood or blood product transfusion.<\/li>\r\n \t<li>Be aware of which types of blood or blood products cause the most types of transfusion reactions.<\/li>\r\n \t<li>Be aware of the types of patients at high risk for blood or blood product transfusion reactions.<\/li>\r\n \t<li>Always have emergency equipment and medications available during a transfusion. For example, epinephrine IV should always be readily available.<\/li>\r\n<\/ul>\r\n<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px; text-align: center;\" colspan=\"3\">\r\n<h4 style=\"text-align: center;\">Steps<\/h4>\r\n<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px; text-align: center;\" colspan=\"2\">\r\n<h4 style=\"text-align: center;\">\u00a0Additional Information<\/h4>\r\n<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">1.\u00a0Stop transfusion immediately.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">The severity of a blood transfusion reaction is related to the amount of product infused and the amount of time it has been infusing.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">2.\u00a0Keep IV line open with 0.9% saline.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Keeps IV site patent for emergency medications if required.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">3.\u00a0Complete cardiovascular and vital signs assessment.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Assessment monitors the type and severity of reaction. In addition to assessment:\r\n<ul>\r\n \t<li>Maintain good urinary output.<\/li>\r\n \t<li>Avoid fluid overload.<\/li>\r\n \t<li>Manage DIC (disseminated intravascular coagulation) or hemorrhage if clinically indicated.<\/li>\r\n \t<li>Provide supportive measures as required (oxygen, etc.).<\/li>\r\n<\/ul>\r\n<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">4.\u00a0Contact physician for medical assessment and to inform about reaction.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">The physician responsible for the patient must be informed of all transfusion reactions.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">5.\u00a0Check vital signs every 15 minutes until stable.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Vital signs must be monitored to identify improving or worsening condition.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">6.\u00a0Obtain blood and urine samples as soon as possible.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Blood and urine samples can help identify the type of blood transfusion reaction.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">7.\u00a0Check all labels, tags, forms, blood order, and patient\u2019s identification band to determine if there is a clerical discrepancy.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Clerical errors account for the majority of blood transfusion reactions.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">8.\u00a0Keep all blood and IV tubing for further testing by the blood bank for verification of blood product and patient identification.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">All blood products and IV tubing are investigated by the transfusion services and reported to Canadian Blood Services and Public Health Agency of Canada. These professional bodies are responsible for reporting and recording incidents of reactions.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">9.\u00a0Notify blood bank.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Notify blood bank when an adverse reaction occurs, even if transfusion is continued.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">10.\u00a0Document as per agency policy.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Document time, date, signs and symptoms, type of product, notification to the physician and management of reaction, and patient response to management of reaction.\r\n\r\nDocumentation includes, but is not limited to:\r\n<ul>\r\n \t<li>Transfusion reaction form<\/li>\r\n \t<li>Patient chart<\/li>\r\n \t<li>Report for transfusion services (blood bank)<\/li>\r\n \t<li>Adverse event form (Patient Safety Learning System or PSLS)<\/li>\r\n<\/ul>\r\n<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"5\">Data source: Alberta Health Services, 2015a; Canadian Blood Services, 2011;\u00a0Perry et al., 2014; Vancouver Coastal Health, 2008<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\nIn preparation for a blood or blood product transfusion (Alberta Health Services, 2015a, 2015b; Perry et al., 2014; Vancouver Coastal Health, 2008), the steps listed in Checklist 74 must be completed.\u00a0These steps must be completed <em>before<\/em> obtaining the blood or blood product from the blood bank.\r\n<table style=\"border-color: #000000; width: 100%;\" border=\"1px solid rgb(0, 0, 0)\"><caption><a id=\"checklist74\"><\/a>Checklist 74: Preparing\u00a0for a Blood or Blood Product Transfusion<\/caption>\r\n<tbody>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 75px; text-align: center;\" colspan=\"5\">\r\n<h5 style=\"text-align: center;\"><span style=\"color: #000000;\">Disclaimer:\u00a0Always review and follow your hospital policy regarding this specific skill.<\/span><\/h5>\r\n<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 75px;\" colspan=\"5\">\r\n<h5><span style=\"color: #333333;\">S<\/span><span style=\"color: #333333;\">afety considerations:\u00a0<\/span><\/h5>\r\n<ul>\r\n \t<li>If there is any discrepancy between patient information, group and screen, product ordered, etc., do not proceed. Stop and verify any discrepancies.<\/li>\r\n \t<li>Be diligent when preparing to infuse blood. Distractions may lead to errors when verifying information.<\/li>\r\n<\/ul>\r\n<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px; text-align: center;\" colspan=\"3\">\r\n<h4 style=\"text-align: center;\">Steps<\/h4>\r\n<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px; text-align: center;\" colspan=\"2\">\r\n<h4 style=\"text-align: center;\">\u00a0Additional Information<\/h4>\r\n<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">1. Verify the physician's order for the specific blood or blood product.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Order must be verified for the type of product;\u00a0the amount, date, time, and rate and duration of infusion; any modifications to a blood component (e.g., irradiation); specific transfusion requirements; and possible sequence in which multiple components are to be transfused.\r\n\r\n[caption id=\"attachment_6804\" align=\"aligncenter\" width=\"197\"]<a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/10\/Sept-22-2015-033.jpg\"><img class=\" wp-image-6804\" src=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/10\/Sept-22-2015-033-300x199.jpg\" alt=\"Physician orders for a blood transfusion\" width=\"197\" height=\"130\" \/><\/a> Physician orders for a blood transfusion[\/caption]<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">2.\u00a0Verify the health care provider's orders for any pre- or post-transfusion medications to be administered.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Some patients may require Benadryl IV or Tylenol pretransfusion or Lasix post-transfusion.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">3.\u00a0Obtain the patient\u2019s transfusion history, and note any known allergies and previous transfusion reactions.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Past complications may require patient to have pre- and post-transfusion medications to prevent further transfusion reactions.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">4.\u00a0Verify that type and cross-match (also known as a G &amp; S) have been completed within the past 96 hours.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Verification allows for the\u00a0identification of any newly developed antibodies, and ensures current compatibility between donor red blood cells and recipient's plasma. If G &amp; S is outdated or not available, initiate process for new G &amp; S sample.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">5. Verify patency of IV site.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">The patient\u2019s IV cannula must be patent and without complications, such as infiltration or phlebitis. The size of cannula (#18 to\u00a0#20) must match the guidelines set by Canadian Blood Services.\r\n\r\n[caption id=\"attachment_6167\" align=\"aligncenter\" width=\"179\"]<a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_0908.jpg\"><img class=\" wp-image-6167\" src=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_0908-300x199.jpg\" alt=\"Assess patency of IV site\" width=\"179\" height=\"119\" \/><\/a> Assess patency of IV site[\/caption]<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">6.\u00a0Ensure appropriate patient identification band is available and legible.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">To complete all safety identification checks, proper identification must be on the patient.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">7.\u00a0Assess laboratory values, such as hematocrit, coagulation values, and platelet count.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">This ensures the transfusion is appropriate for the patient.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">8.\u00a0Check that the patient has properly completed and signed the transfusion consent form.\r\n\r\nAssess patient's understanding of the procedure and its rationale. Consent is required for the transfusion of blood and blood components and products.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">All blood products must have a consent form signed prior to the transfusion.\r\n\r\n[caption id=\"attachment_6515\" align=\"aligncenter\" width=\"115\"]<a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-019.jpg\"><img class=\" wp-image-6515\" src=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-019-201x300.jpg\" alt=\"Consent\" width=\"115\" height=\"172\" \/><\/a> Example of a consent form[\/caption]\r\n\r\nConsent is mandatory for all blood and blood product transfusions. Follow agency policy if patient is unable to sign or consent to blood or blood product transfusions.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">9.\u00a0Know the indications for the transfusion.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Know why the patient is receiving the transfusion.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">10.\u00a0Obtain and record the patient\u2019s pretransfusion baseline vital signs, including temperature, pulse, respiration, blood pressure, and oxygen saturation level. If the patient is febrile, which means the patient's temperature is higher than 37.8\u00b0C (100\u00b0F), notify the health care provider before initiating the transfusion.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Pretransfusion vital signs are a mandatory component of blood administration.\r\n\r\n[caption id=\"attachment_6464\" align=\"aligncenter\" width=\"124\"]<a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-107.jpg\"><img class=\" wp-image-6464\" src=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-107-209x300.jpg\" alt=\"Pre-assessment of vital signs\" width=\"124\" height=\"178\" \/><\/a> Pre-assessment of vital signs[\/caption]<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">11.\u00a0Have emergency equipment available at the bedside (oxygen, suction, etc.).<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Be prepared for potential complications, as prompt intervention may be required to prevent serious complications.\r\n\r\n[caption id=\"attachment_6428\" align=\"aligncenter\" width=\"165\"]<a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_2294.jpg\"><img class=\"wp-image-6428\" src=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_2294-300x199.jpg\" alt=\"Emergency equipment at bedside\" width=\"165\" height=\"109\" \/><\/a> Emergency equipment check at bedside[\/caption]<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">12. Complete all documentation as required per agency policy.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Proper documentation provides evidence that all required procedures have been followed to prepare for a transfusion.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"5\">Data source: Alberta Health Services, 2015b; Canadian Blood Services, 2011;\u00a0Perry et al., 2014; Vancouver Coastal Health, 2008<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\nChecklist 75 provides steps to administering blood and blood products safely in the acute care setting.\r\n<table style=\"border-color: #000000; width: 100%;\" border=\"1px solid rgb(0, 0, 0)\"><caption><a id=\"checklist75\"><\/a>Checklist 75: Transfusion of Blood and Blood Products<\/caption>\r\n<tbody>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 75px; text-align: center;\" colspan=\"5\">\r\n<h5 style=\"text-align: center;\"><span style=\"color: #000000;\">Disclaimer:\u00a0Always review and follow your hospital policy regarding this specific skill.<\/span><\/h5>\r\n<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 75px;\" colspan=\"5\">\r\n<h5><span style=\"color: #333333;\">Safety considerations:\u00a0<\/span><\/h5>\r\n<ul>\r\n \t<li>No medications may be added to blood units or through IV tubing.<\/li>\r\n \t<li>Specific blood administration tubing is required for all blood transfusions. Blood tubing is changed every 4 hours or 4 units, whichever comes first.<\/li>\r\n \t<li>See agency policy for using EID for the administration of blood products.<\/li>\r\n \t<li>Intravenous immunoglobulin (IVIG) is only compatible with D5W.<\/li>\r\n \t<li>All blood products taken from the blood bank must be hung within 30 minutes and administered (infused) within 4 hours due to the risk of bacterial proliferation in the blood component at room temperature.<\/li>\r\n<\/ul>\r\n<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px; text-align: center;\" colspan=\"3\">\r\n<h4 style=\"text-align: center;\">Steps<\/h4>\r\n<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px; text-align: center;\" colspan=\"2\">\r\n<h4 style=\"text-align: center;\">\u00a0Additional Information<\/h4>\r\n<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">1. Verify physician orders and all preparation steps as listed in <a href=\"#checklist74\">Checklist 74<\/a>.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\"><\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">2. Assess or initiate venous access.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Appropriate needle gauge is based on clinical status of patient, urgency of transfusion, and venous access:\r\n<ul>\r\n \t<li>#18 gauge for trauma\/surgery<\/li>\r\n \t<li>#20 to\u00a0#22 for elective medical\/geriatric<\/li>\r\n<\/ul>\r\nTransfusion set must be Luer-locked to a 2.0 ml maximum extension tubing, either directly to cannula or through a Max Plus positive pressure cap.\r\n\r\n[caption id=\"attachment_6190\" align=\"aligncenter\" width=\"157\"]<a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_0930.jpg\"><img class=\" wp-image-6190\" src=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_0930-300x199.jpg\" alt=\"Saline lock\" width=\"157\" height=\"104\" \/><\/a> Saline lock[\/caption]<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">3. Initiate primary infusion at TKVO.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Prime an IV line following Checklist 66.\r\n<ul>\r\n \t<li>0.9% NS for RBC<\/li>\r\n \t<li>D5W for IVIG<\/li>\r\n<\/ul>\r\nRefer to blood product fact sheets for all other products.\r\n\r\n[caption id=\"attachment_6234\" align=\"aligncenter\" width=\"92\"]<a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Book-pictures-2015-014-e1442759268323.jpg\"><img class=\"wp-image-6234\" src=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Book-pictures-2015-014-e1442759268323-199x300.jpg\" alt=\"Sterile IV solution\" width=\"92\" height=\"139\" \/><\/a> Normal saline IV solution[\/caption]<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">4. Complete and document cardiovascular assessments and initial vital signs.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Document any clinical sign or symptom that may be confused with a transfusion reaction (e.g., existing fever).<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">5. Obtain products from the transfusion areas within 30 minutes of planned transfusion.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Plan for pickup or delivery of blood and blood products. Do not request blood or blood products if Steps 1 to 4 are not complete.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">6. Complete visual inspection of product.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Assess blood bag for\u00a0any signs of leaks or contamination, such as clumping, clots, gas bubbles, or a purplish discoloration. Return to blood bank if blood bag contains any of the above signs.\r\n\r\n[caption id=\"attachment_5762\" align=\"aligncenter\" width=\"154\"]<a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_1159-e1442761701412.jpg\"><img class=\" wp-image-5762\" src=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_1159-e1442761701412-300x199.jpg\" alt=\"Visual inspection of the blood bag\" width=\"154\" height=\"102\" \/><\/a> Visual inspection of the blood bag[\/caption]<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">7. Initial verification:\r\n\r\na. Compare the <strong>transfusion medical services<\/strong> (TMS) documentation with the patient record to verify:\r\n<ul>\r\n \t<li>Patient first and last name and unique identifier number<\/li>\r\n \t<li>Physician order<\/li>\r\n \t<li>Consent<\/li>\r\n \t<li>Patient ABO grouping (G &amp; S)<\/li>\r\n<\/ul>\r\nb. Compare the TMS documentation with the product label attached to the product tab and verify:\r\n<ul>\r\n \t<li>Patient first and last name and unique identifier number<\/li>\r\n \t<li>Type of blood product and ABO blood grouping<\/li>\r\n \t<li>11-digit serial number<\/li>\r\n \t<li>Product expiry date and time<\/li>\r\n \t<li>Special requirements (e.g., irradiated)<\/li>\r\n \t<li>G &amp; S expiry date<\/li>\r\n<\/ul>\r\n<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">All verification numbers\/information must match exactly.\r\n\r\nMust be completed by two trained staff members competent in blood transfusion administration process as set out by the agency.\r\n\r\nConfirm the patient blood type and Rh are compatible with the donor blood type and Rh.\r\n\r\nIf there are any discrepancies, stop the process and contact the TMS for resolution and direction. Do not proceed.\r\n\r\nEnsure the blood product matches the physician's orders (red blood cells or platelets).\r\n\r\n[caption id=\"attachment_6516\" align=\"aligncenter\" width=\"152\"]<a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-033.jpg\"><img class=\" wp-image-6516\" src=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-033-300x199.jpg\" alt=\"TMS record\" width=\"152\" height=\"101\" \/><\/a> TMS record[\/caption]<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">8 Administer pre-medications as ordered.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Medications must be administered through an IV infusion set, and the IV site cleared with 0.9% NS.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">9. Final verification (must be completed by the same two staff members as noted in Step 7).\r\n\r\nCompare the patient's first and last name and unique identifier number using all of the following:\r\n<ul>\r\n \t<li>Patient identification band or equivalent ID process as approved by the TMS (Ask the patient to spell first and last name and state date of birth.)<\/li>\r\n \t<li>TMS documentation<\/li>\r\n \t<li>Compatibility tag and label attached to blood product<\/li>\r\n<\/ul>\r\nOnly after recipient identification and product check is confirmed, invert product 5 to\u00a010 times and insert spike of the blood administration set into the blood product container.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">All verification numbers must match exactly. If there are any discrepancies, stop the process and contact the TMS for resolution and direction. Do not proceed.\r\n\r\n[caption id=\"attachment_6517\" align=\"aligncenter\" width=\"184\"]<a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-032.jpg\"><img class=\"wp-image-6517\" src=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-032-300x208.jpg\" alt=\"Identify patient\" width=\"184\" height=\"128\" \/><\/a> Identify patient[\/caption]\r\n\r\nPatients who are alert and oriented should be asked to:\r\n<ul>\r\n \t<li>Spell first and last name<\/li>\r\n \t<li>State their date of birth<\/li>\r\n<\/ul>\r\nAll identifying information attached to the blood bag must remain attached at least until completion of transfusion.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">10. Perform hand hygiene. Prime the blood product administration set:\r\n<ul>\r\n \t<li>Close clamp. Completely cover the filter with product.<\/li>\r\n \t<li>A straight blood administration set is used for all transfusions.<\/li>\r\n \t<li>A Y-type blood administration set should only be considered in clinical situations where additional fluid volume may be required.<\/li>\r\n<\/ul>\r\n<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Do not remove the product from the presence of the patient; prime at bedside. If product is removed from bedside, the final verification process must be completed again.\r\n\r\n[caption id=\"attachment_5773\" align=\"aligncenter\" width=\"155\"]<a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_1178-e1442761410159.jpg\"><img class=\" wp-image-5773\" src=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_1178-e1442761410159-199x300.jpg\" alt=\"Prime blood tubing\" width=\"155\" height=\"234\" \/><\/a> Prime blood tubing[\/caption]<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">11. Initiate transfusion:\r\n<ul>\r\n \t<li>Obtain vital signs immediately prior to transfusion, then 15 minutes after initiation, then every hour until transfusion is complete.<\/li>\r\n \t<li>Maintaining asepsis, disconnect the NS infusion and connect blood administration set and start transfusion.<\/li>\r\n \t<li>Advise patient on the signs and symptoms of transfusion reaction and what and when to report.<\/li>\r\n<\/ul>\r\n<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Adults: Initiate red cells slowly (25 ml in the first 15 minutes). For all other blood transfusions, refer to the blood and product sheet as per your agency policy.\r\n\r\nSome agencies use an EID to administer blood transfusions. Always check agency policy prior to transfusion.\r\n\r\nFor each and every unit:\r\n<ul>\r\n \t<li>Remain with the patient for the first 5 minutes and assess for clinical signs of transfusion reaction.<\/li>\r\n \t<li>Complete transfusion within 4 hours of removal from the blood bank.<\/li>\r\n<\/ul>\r\nMost transfusion reactions occur within first 15 minutes of a transfusion.\u00a0Infusing small amounts of blood component initially minimizes volume of blood to which patient is exposed, thereby minimizing severity of reaction.\r\n\r\n[caption id=\"attachment_5792\" align=\"aligncenter\" width=\"190\"]<a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_1200-e1442761865948.jpg\"><img class=\" wp-image-5792\" src=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_1200-e1442761865948-300x199.jpg\" alt=\"Infusion of packed RBC\" width=\"190\" height=\"126\" \/><\/a> Infusion of packed red blood cells[\/caption]<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">12. Monitor:\r\n<ul>\r\n \t<li>Assess and observe for clinical signs and symptoms of reactions up to 24 hours post-transfusion.<\/li>\r\n \t<li>Complete all appropriate clinical documentation.<\/li>\r\n<\/ul>\r\n<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Vital signs must be monitored:\r\n<ul>\r\n \t<li>Immediately prior to infusion<\/li>\r\n \t<li>Within 10 to\u00a015 minutes<\/li>\r\n \t<li>Every hour until transfusion is complete<\/li>\r\n<\/ul>\r\n[caption id=\"attachment_6464\" align=\"aligncenter\" width=\"120\"]<a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-107.jpg\"><img class=\" wp-image-6464\" src=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-107-209x300.jpg\" alt=\"vital signs\" width=\"120\" height=\"173\" \/><\/a> Vital signs[\/caption]<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">13. In the event of a transfusion reaction, stop the infusion.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">\r\n<ul>\r\n \t<li>Manage transfusion reactions as per protocol.<\/li>\r\n \t<li>Complete required transfusion reaction form.<\/li>\r\n \t<li>Return remaining blood to blood bank for further investigation.<\/li>\r\n<\/ul>\r\n<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">14. For additional units, repeat steps 6 to 12.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Follow the same process to ensure patient safety.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">15. Flush administration set with maximum of 50 ml of normal saline and re-establish IV or SL as per physician orders.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Flushing displaces any blood or blood product from the administration set. It is not necessary to flush between units of the same blood product.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">16. Discard waste in biohazard waste container.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">This prevents the spread of biohazard waste.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">17. Complete all documentation as required by agency.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Documentation may include:\r\n<ul>\r\n \t<li>Transfusion record form<\/li>\r\n \t<li>All vital signs and reactions<\/li>\r\n \t<li>Any significant findings, initiation and termination of transfusion<\/li>\r\n \t<li>Record of transfusion on the in-and-out sheet<\/li>\r\n<\/ul>\r\n<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"5\">Data source: Alberta Health Services, 2015a, 2015b; Perry et al., 2014; Vancouver Coastal Health, 2008<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n<div class=\"textbox textbox--exercises\"><header class=\"textbox__header\">\r\n<p class=\"textbox__title\">Critical Thinking Exercises<\/p>\r\n\r\n<\/header>\r\n<div class=\"textbox__content\">\r\n<ol>\r\n \t<li>How many units of blood can be transfused through one blood administration set?<\/li>\r\n \t<li>What are the steps to managing a blood transfusion reaction?<\/li>\r\n<\/ol>\r\n<\/div>\r\n<\/div>","rendered":"<p>All health care practitioners who administer blood or blood products must complete specific training for safe transfusion practices and be competent in the transfusion administration process. Always refer to your agency policy for guidelines for preparing, initiating, and monitoring blood and blood product transfusions. These guidelines apply to adult patients only.<\/p>\n<p>The transfusion of blood or blood products (see Figure 8.8) is the administration of whole blood, its components, or plasma-derived products. The primary indication for a red blood cell (RBC) transfusion is to improve the oxygen-carrying capacity of the blood (Canadian Blood Services, 2013). A health care provider order is required for the transfusion of blood or blood products. RBC transfusions are indicated in patients with anemia who have evidence of impaired oxygen delivery. For example, individuals with acute blood loss, chronic anemia and cardiopulmonary compromise, or disease or medication effects associated with bone marrow suppression may be candidates for RBC transfusion. In patients with acute blood loss, volume replacement is often more critical than the composition of the replacing fluids (Canadian Blood Services, 2013). Transfusions can restore blood volume, restore oxygen-carrying capacity of blood with red blood cells, and provide platelets and clotting factors. The most common type of blood transfusion is blood that is donated by another person (allogeneic). Autologous transfusion is the transfusion of one&#8217;s own blood (Perry et al., 2014).<\/p>\n<figure id=\"attachment_5795\" aria-describedby=\"caption-attachment-5795\" style=\"width: 199px\" class=\"wp-caption aligncenter\"><a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_1204-e1443928446983.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-5795 size-medium\" src=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_1204-e1443928446983-199x300.jpg\" alt=\"Red Blood Cells and Blood IV tubing\" width=\"199\" height=\"300\" srcset=\"https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_1204-e1443928446983-199x300.jpg 199w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_1204-e1443928446983-678x1024.jpg 678w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_1204-e1443928446983-65x98.jpg 65w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_1204-e1443928446983-225x340.jpg 225w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_1204-e1443928446983-350x528.jpg 350w\" sizes=\"auto, (max-width: 199px) 100vw, 199px\" \/><\/a><figcaption id=\"caption-attachment-5795\" class=\"wp-caption-text\">Figure 8.8 Red blood cells and blood IV tubing<\/figcaption><\/figure>\n<p>Transfusion therapy is considered safe, and stringent precautions are followed in the collection, processing, and administration of blood and blood components. However, transfusions still carry risks such as incompatibility, human error, and disease transmission, and\u00a0blood transfusion must be taken seriously at all times. Incompatibility can be decreased by using irradiated red blood cells or leukocyte-reduced blood. The majority of blood transfusion complications are a result of human error (Perry et al., 2014).<\/p>\n<p>Compatibility testing is vital for all recipients of blood or blood products. Recipients must be transfused with an ABO group specific to their own blood type or ABO group-compatible. There are three types of blood typing systems:\u00a0ABO, Rh, and human leukocyte antigen (HLA). For more information on these, refer to the online resources at the end of this chapter. It is vital to understand what types of blood groups are compatible for transfusions (Canadian Blood Services, 2013).<\/p>\n<p>When administering blood and blood products, it is important to know the patient&#8217;s values and beliefs regarding blood products. Some groups of individuals, mainly Jehovah Witnesses, will refuse blood transfusions or blood products based on religious beliefs. These individuals will refuse transfusion of whole blood and primary blood components but may accept transfusion of derivatives of primary blood components such as albumins solutions, clotting factors and immunoglobulins. Always assess each individual preference to establish if a blood component is an acceptable treatment to manage their illness or condition (Canadian Blood Services, 2007).<\/p>\n<p>When managing blood transfusions, it is important to prevent complications from occurring and to identify issues promptly to manage reactions effectively. Transfusion reactions (mild to life-threatening) may occur despite all safety measures taken. All transfusion reactions and transfusion errors must be reported to the hospital&#8217;s transfusion services (blood bank). It is imperative to know what signs and symptoms to look for, and to educate your patient on what to report and when to report potential transfusion reactions. Mild to severe reactions may include (Canadian Blood Services, 2011):<\/p>\n<ul>\n<li>Temperature \u2265 38.0 C or change of 1\u00b0C from pretransfusion value within 15 minutes after initiation of transfusion<\/li>\n<li>Acute or delayed hemolytic transfusion reaction<\/li>\n<li>Hypotension\/shock<\/li>\n<li>Rigors<\/li>\n<li>Anxiety<\/li>\n<li>Back or chest pain<\/li>\n<li>Nausea\/vomiting<\/li>\n<li>Shortness of breath (dyspnea)<\/li>\n<li>Hemoglobinuria<\/li>\n<li>Bleeding\/pain at IV site<\/li>\n<li>Tachycardia\/arrhythmia<\/li>\n<li>Generalized flushing<\/li>\n<li>Rash \u2265 25% of body<\/li>\n<li>Urticaria and other anaphylaxis reactions<\/li>\n<li>Hemolysis after transfusion<\/li>\n<li>Cytopenias after transfusion<\/li>\n<li>Virus, parasite, and prion infections<\/li>\n<li>Non-immunological reactions including infection<\/li>\n<li>Circulatory overload<\/li>\n<li>Hypothermia<\/li>\n<\/ul>\n<p>For more information on types of reactions, signs and symptoms, and treatments, review the article <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4260299\/\" target=\"_blank\" rel=\"noopener noreferrer\">adverse events related to blood transfusions<\/a>, or see the online resources at the end of this chapter.\u00a0If patient has a blood transfusion reaction, always follow agency policy to manage mild to severe blood reactions. In general, if a reaction occurs, follow the steps outlined in Checklist 73.<\/p>\n<table style=\"border-color: #000000; width: 100%;\">\n<caption><a id=\"checklist73\"><\/a>Checklist 73: Managing a Blood or Blood Product Transfusion Reaction<\/caption>\n<tbody>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 75px; text-align: center;\" colspan=\"5\">\n<h5 style=\"text-align: center;\"><span style=\"color: #000000;\">Disclaimer:\u00a0Always review and follow your hospital policy regarding this specific skill.<\/span><\/h5>\n<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 75px;\" colspan=\"5\">\n<h5><span style=\"color: #333333;\">Safety considerations:<\/span><em><span style=\"color: #333333;\">\u00a0<\/span><\/em><\/h5>\n<ul>\n<li>Always review your agency&#8217;s algorithm for managing mild to severe reactions. If a reaction is mild (e.g., fever), and without any other complications, a patient may continue the transfusion if monitored closely. Most other transfusion reactions require the transfusion to be stopped immediately.<\/li>\n<li>A blood transfusion reaction may occur 24 to 48 hours post-transfusion.<\/li>\n<li>Each separate unit presents a potential for an adverse reaction.<\/li>\n<li>Follow emergency transfusion guidelines when dealing with an emergency blood or blood product transfusion.<\/li>\n<li>Be aware of which types of blood or blood products cause the most types of transfusion reactions.<\/li>\n<li>Be aware of the types of patients at high risk for blood or blood product transfusion reactions.<\/li>\n<li>Always have emergency equipment and medications available during a transfusion. For example, epinephrine IV should always be readily available.<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px; text-align: center;\" colspan=\"3\">\n<h4 style=\"text-align: center;\">Steps<\/h4>\n<\/td>\n<td style=\"border: 1px solid #000000; width: 250px; text-align: center;\" colspan=\"2\">\n<h4 style=\"text-align: center;\">\u00a0Additional Information<\/h4>\n<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">1.\u00a0Stop transfusion immediately.<\/td>\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">The severity of a blood transfusion reaction is related to the amount of product infused and the amount of time it has been infusing.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">2.\u00a0Keep IV line open with 0.9% saline.<\/td>\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Keeps IV site patent for emergency medications if required.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">3.\u00a0Complete cardiovascular and vital signs assessment.<\/td>\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Assessment monitors the type and severity of reaction. In addition to assessment:<\/p>\n<ul>\n<li>Maintain good urinary output.<\/li>\n<li>Avoid fluid overload.<\/li>\n<li>Manage DIC (disseminated intravascular coagulation) or hemorrhage if clinically indicated.<\/li>\n<li>Provide supportive measures as required (oxygen, etc.).<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">4.\u00a0Contact physician for medical assessment and to inform about reaction.<\/td>\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">The physician responsible for the patient must be informed of all transfusion reactions.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">5.\u00a0Check vital signs every 15 minutes until stable.<\/td>\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Vital signs must be monitored to identify improving or worsening condition.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">6.\u00a0Obtain blood and urine samples as soon as possible.<\/td>\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Blood and urine samples can help identify the type of blood transfusion reaction.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">7.\u00a0Check all labels, tags, forms, blood order, and patient\u2019s identification band to determine if there is a clerical discrepancy.<\/td>\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Clerical errors account for the majority of blood transfusion reactions.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">8.\u00a0Keep all blood and IV tubing for further testing by the blood bank for verification of blood product and patient identification.<\/td>\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">All blood products and IV tubing are investigated by the transfusion services and reported to Canadian Blood Services and Public Health Agency of Canada. These professional bodies are responsible for reporting and recording incidents of reactions.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">9.\u00a0Notify blood bank.<\/td>\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Notify blood bank when an adverse reaction occurs, even if transfusion is continued.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">10.\u00a0Document as per agency policy.<\/td>\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Document time, date, signs and symptoms, type of product, notification to the physician and management of reaction, and patient response to management of reaction.<\/p>\n<p>Documentation includes, but is not limited to:<\/p>\n<ul>\n<li>Transfusion reaction form<\/li>\n<li>Patient chart<\/li>\n<li>Report for transfusion services (blood bank)<\/li>\n<li>Adverse event form (Patient Safety Learning System or PSLS)<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"5\">Data source: Alberta Health Services, 2015a; Canadian Blood Services, 2011;\u00a0Perry et al., 2014; Vancouver Coastal Health, 2008<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>In preparation for a blood or blood product transfusion (Alberta Health Services, 2015a, 2015b; Perry et al., 2014; Vancouver Coastal Health, 2008), the steps listed in Checklist 74 must be completed.\u00a0These steps must be completed <em>before<\/em> obtaining the blood or blood product from the blood bank.<\/p>\n<table style=\"border-color: #000000; width: 100%;\">\n<caption><a id=\"checklist74\"><\/a>Checklist 74: Preparing\u00a0for a Blood or Blood Product Transfusion<\/caption>\n<tbody>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 75px; text-align: center;\" colspan=\"5\">\n<h5 style=\"text-align: center;\"><span style=\"color: #000000;\">Disclaimer:\u00a0Always review and follow your hospital policy regarding this specific skill.<\/span><\/h5>\n<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 75px;\" colspan=\"5\">\n<h5><span style=\"color: #333333;\">S<\/span><span style=\"color: #333333;\">afety considerations:\u00a0<\/span><\/h5>\n<ul>\n<li>If there is any discrepancy between patient information, group and screen, product ordered, etc., do not proceed. Stop and verify any discrepancies.<\/li>\n<li>Be diligent when preparing to infuse blood. Distractions may lead to errors when verifying information.<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px; text-align: center;\" colspan=\"3\">\n<h4 style=\"text-align: center;\">Steps<\/h4>\n<\/td>\n<td style=\"border: 1px solid #000000; width: 250px; text-align: center;\" colspan=\"2\">\n<h4 style=\"text-align: center;\">\u00a0Additional Information<\/h4>\n<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">1. Verify the physician&#8217;s order for the specific blood or blood product.<\/td>\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Order must be verified for the type of product;\u00a0the amount, date, time, and rate and duration of infusion; any modifications to a blood component (e.g., irradiation); specific transfusion requirements; and possible sequence in which multiple components are to be transfused.<\/p>\n<figure id=\"attachment_6804\" aria-describedby=\"caption-attachment-6804\" style=\"width: 197px\" class=\"wp-caption aligncenter\"><a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/10\/Sept-22-2015-033.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-6804\" src=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/10\/Sept-22-2015-033-300x199.jpg\" alt=\"Physician orders for a blood transfusion\" width=\"197\" height=\"130\" srcset=\"https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/10\/Sept-22-2015-033-300x199.jpg 300w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/10\/Sept-22-2015-033-1024x678.jpg 1024w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/10\/Sept-22-2015-033-65x43.jpg 65w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/10\/Sept-22-2015-033-225x149.jpg 225w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/10\/Sept-22-2015-033-350x232.jpg 350w\" sizes=\"auto, (max-width: 197px) 100vw, 197px\" \/><\/a><figcaption id=\"caption-attachment-6804\" class=\"wp-caption-text\">Physician orders for a blood transfusion<\/figcaption><\/figure>\n<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">2.\u00a0Verify the health care provider&#8217;s orders for any pre- or post-transfusion medications to be administered.<\/td>\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Some patients may require Benadryl IV or Tylenol pretransfusion or Lasix post-transfusion.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">3.\u00a0Obtain the patient\u2019s transfusion history, and note any known allergies and previous transfusion reactions.<\/td>\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Past complications may require patient to have pre- and post-transfusion medications to prevent further transfusion reactions.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">4.\u00a0Verify that type and cross-match (also known as a G &amp; S) have been completed within the past 96 hours.<\/td>\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Verification allows for the\u00a0identification of any newly developed antibodies, and ensures current compatibility between donor red blood cells and recipient&#8217;s plasma. If G &amp; S is outdated or not available, initiate process for new G &amp; S sample.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">5. Verify patency of IV site.<\/td>\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">The patient\u2019s IV cannula must be patent and without complications, such as infiltration or phlebitis. The size of cannula (#18 to\u00a0#20) must match the guidelines set by Canadian Blood Services.<\/p>\n<figure id=\"attachment_6167\" aria-describedby=\"caption-attachment-6167\" style=\"width: 179px\" class=\"wp-caption aligncenter\"><a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_0908.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-6167\" src=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_0908-300x199.jpg\" alt=\"Assess patency of IV site\" width=\"179\" height=\"119\" srcset=\"https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_0908-300x199.jpg 300w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_0908-1024x678.jpg 1024w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_0908-65x43.jpg 65w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_0908-225x149.jpg 225w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_0908-350x232.jpg 350w\" sizes=\"auto, (max-width: 179px) 100vw, 179px\" \/><\/a><figcaption id=\"caption-attachment-6167\" class=\"wp-caption-text\">Assess patency of IV site<\/figcaption><\/figure>\n<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">6.\u00a0Ensure appropriate patient identification band is available and legible.<\/td>\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">To complete all safety identification checks, proper identification must be on the patient.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">7.\u00a0Assess laboratory values, such as hematocrit, coagulation values, and platelet count.<\/td>\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">This ensures the transfusion is appropriate for the patient.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">8.\u00a0Check that the patient has properly completed and signed the transfusion consent form.<\/p>\n<p>Assess patient&#8217;s understanding of the procedure and its rationale. Consent is required for the transfusion of blood and blood components and products.<\/td>\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">All blood products must have a consent form signed prior to the transfusion.<\/p>\n<figure id=\"attachment_6515\" aria-describedby=\"caption-attachment-6515\" style=\"width: 115px\" class=\"wp-caption aligncenter\"><a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-019.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-6515\" src=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-019-201x300.jpg\" alt=\"Consent\" width=\"115\" height=\"172\" srcset=\"https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-019-201x300.jpg 201w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-019.jpg 685w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-019-65x97.jpg 65w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-019-225x336.jpg 225w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-019-350x523.jpg 350w\" sizes=\"auto, (max-width: 115px) 100vw, 115px\" \/><\/a><figcaption id=\"caption-attachment-6515\" class=\"wp-caption-text\">Example of a consent form<\/figcaption><\/figure>\n<p>Consent is mandatory for all blood and blood product transfusions. Follow agency policy if patient is unable to sign or consent to blood or blood product transfusions.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">9.\u00a0Know the indications for the transfusion.<\/td>\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Know why the patient is receiving the transfusion.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">10.\u00a0Obtain and record the patient\u2019s pretransfusion baseline vital signs, including temperature, pulse, respiration, blood pressure, and oxygen saturation level. If the patient is febrile, which means the patient&#8217;s temperature is higher than 37.8\u00b0C (100\u00b0F), notify the health care provider before initiating the transfusion.<\/td>\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Pretransfusion vital signs are a mandatory component of blood administration.<\/p>\n<figure id=\"attachment_6464\" aria-describedby=\"caption-attachment-6464\" style=\"width: 124px\" class=\"wp-caption aligncenter\"><a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-107.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-6464\" src=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-107-209x300.jpg\" alt=\"Pre-assessment of vital signs\" width=\"124\" height=\"178\" srcset=\"https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-107-209x300.jpg 209w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-107.jpg 713w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-107-65x93.jpg 65w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-107-225x323.jpg 225w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-107-350x503.jpg 350w\" sizes=\"auto, (max-width: 124px) 100vw, 124px\" \/><\/a><figcaption id=\"caption-attachment-6464\" class=\"wp-caption-text\">Pre-assessment of vital signs<\/figcaption><\/figure>\n<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">11.\u00a0Have emergency equipment available at the bedside (oxygen, suction, etc.).<\/td>\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Be prepared for potential complications, as prompt intervention may be required to prevent serious complications.<\/p>\n<figure id=\"attachment_6428\" aria-describedby=\"caption-attachment-6428\" style=\"width: 165px\" class=\"wp-caption aligncenter\"><a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_2294.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-6428\" src=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_2294-300x199.jpg\" alt=\"Emergency equipment at bedside\" width=\"165\" height=\"109\" srcset=\"https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_2294-300x199.jpg 300w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_2294-1024x678.jpg 1024w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_2294-65x43.jpg 65w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_2294-225x149.jpg 225w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_2294-350x232.jpg 350w\" sizes=\"auto, (max-width: 165px) 100vw, 165px\" \/><\/a><figcaption id=\"caption-attachment-6428\" class=\"wp-caption-text\">Emergency equipment check at bedside<\/figcaption><\/figure>\n<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">12. Complete all documentation as required per agency policy.<\/td>\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Proper documentation provides evidence that all required procedures have been followed to prepare for a transfusion.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"5\">Data source: Alberta Health Services, 2015b; Canadian Blood Services, 2011;\u00a0Perry et al., 2014; Vancouver Coastal Health, 2008<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Checklist 75 provides steps to administering blood and blood products safely in the acute care setting.<\/p>\n<table style=\"border-color: #000000; width: 100%;\">\n<caption><a id=\"checklist75\"><\/a>Checklist 75: Transfusion of Blood and Blood Products<\/caption>\n<tbody>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 75px; text-align: center;\" colspan=\"5\">\n<h5 style=\"text-align: center;\"><span style=\"color: #000000;\">Disclaimer:\u00a0Always review and follow your hospital policy regarding this specific skill.<\/span><\/h5>\n<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 75px;\" colspan=\"5\">\n<h5><span style=\"color: #333333;\">Safety considerations:\u00a0<\/span><\/h5>\n<ul>\n<li>No medications may be added to blood units or through IV tubing.<\/li>\n<li>Specific blood administration tubing is required for all blood transfusions. Blood tubing is changed every 4 hours or 4 units, whichever comes first.<\/li>\n<li>See agency policy for using EID for the administration of blood products.<\/li>\n<li>Intravenous immunoglobulin (IVIG) is only compatible with D5W.<\/li>\n<li>All blood products taken from the blood bank must be hung within 30 minutes and administered (infused) within 4 hours due to the risk of bacterial proliferation in the blood component at room temperature.<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px; text-align: center;\" colspan=\"3\">\n<h4 style=\"text-align: center;\">Steps<\/h4>\n<\/td>\n<td style=\"border: 1px solid #000000; width: 250px; text-align: center;\" colspan=\"2\">\n<h4 style=\"text-align: center;\">\u00a0Additional Information<\/h4>\n<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">1. Verify physician orders and all preparation steps as listed in <a href=\"#checklist74\">Checklist 74<\/a>.<\/td>\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\"><\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">2. Assess or initiate venous access.<\/td>\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Appropriate needle gauge is based on clinical status of patient, urgency of transfusion, and venous access:<\/p>\n<ul>\n<li>#18 gauge for trauma\/surgery<\/li>\n<li>#20 to\u00a0#22 for elective medical\/geriatric<\/li>\n<\/ul>\n<p>Transfusion set must be Luer-locked to a 2.0 ml maximum extension tubing, either directly to cannula or through a Max Plus positive pressure cap.<\/p>\n<figure id=\"attachment_6190\" aria-describedby=\"caption-attachment-6190\" style=\"width: 157px\" class=\"wp-caption aligncenter\"><a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_0930.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-6190\" src=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_0930-300x199.jpg\" alt=\"Saline lock\" width=\"157\" height=\"104\" srcset=\"https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_0930-300x199.jpg 300w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_0930-1024x678.jpg 1024w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_0930-65x43.jpg 65w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_0930-225x149.jpg 225w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_0930-350x232.jpg 350w\" sizes=\"auto, (max-width: 157px) 100vw, 157px\" \/><\/a><figcaption id=\"caption-attachment-6190\" class=\"wp-caption-text\">Saline lock<\/figcaption><\/figure>\n<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">3. Initiate primary infusion at TKVO.<\/td>\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Prime an IV line following Checklist 66.<\/p>\n<ul>\n<li>0.9% NS for RBC<\/li>\n<li>D5W for IVIG<\/li>\n<\/ul>\n<p>Refer to blood product fact sheets for all other products.<\/p>\n<figure id=\"attachment_6234\" aria-describedby=\"caption-attachment-6234\" style=\"width: 92px\" class=\"wp-caption aligncenter\"><a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Book-pictures-2015-014-e1442759268323.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-6234\" src=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Book-pictures-2015-014-e1442759268323-199x300.jpg\" alt=\"Sterile IV solution\" width=\"92\" height=\"139\" srcset=\"https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Book-pictures-2015-014-e1442759268323-199x300.jpg 199w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Book-pictures-2015-014-e1442759268323-678x1024.jpg 678w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Book-pictures-2015-014-e1442759268323-65x98.jpg 65w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Book-pictures-2015-014-e1442759268323-225x340.jpg 225w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Book-pictures-2015-014-e1442759268323-350x528.jpg 350w\" sizes=\"auto, (max-width: 92px) 100vw, 92px\" \/><\/a><figcaption id=\"caption-attachment-6234\" class=\"wp-caption-text\">Normal saline IV solution<\/figcaption><\/figure>\n<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">4. Complete and document cardiovascular assessments and initial vital signs.<\/td>\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Document any clinical sign or symptom that may be confused with a transfusion reaction (e.g., existing fever).<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">5. Obtain products from the transfusion areas within 30 minutes of planned transfusion.<\/td>\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Plan for pickup or delivery of blood and blood products. Do not request blood or blood products if Steps 1 to 4 are not complete.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">6. Complete visual inspection of product.<\/td>\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Assess blood bag for\u00a0any signs of leaks or contamination, such as clumping, clots, gas bubbles, or a purplish discoloration. Return to blood bank if blood bag contains any of the above signs.<\/p>\n<figure id=\"attachment_5762\" aria-describedby=\"caption-attachment-5762\" style=\"width: 154px\" class=\"wp-caption aligncenter\"><a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_1159-e1442761701412.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-5762\" src=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_1159-e1442761701412-300x199.jpg\" alt=\"Visual inspection of the blood bag\" width=\"154\" height=\"102\" srcset=\"https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_1159-e1442761701412-300x199.jpg 300w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_1159-e1442761701412-1024x678.jpg 1024w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_1159-e1442761701412-65x43.jpg 65w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_1159-e1442761701412-225x149.jpg 225w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_1159-e1442761701412-350x232.jpg 350w\" sizes=\"auto, (max-width: 154px) 100vw, 154px\" \/><\/a><figcaption id=\"caption-attachment-5762\" class=\"wp-caption-text\">Visual inspection of the blood bag<\/figcaption><\/figure>\n<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">7. Initial verification:<\/p>\n<p>a. Compare the <strong>transfusion medical services<\/strong> (TMS) documentation with the patient record to verify:<\/p>\n<ul>\n<li>Patient first and last name and unique identifier number<\/li>\n<li>Physician order<\/li>\n<li>Consent<\/li>\n<li>Patient ABO grouping (G &amp; S)<\/li>\n<\/ul>\n<p>b. Compare the TMS documentation with the product label attached to the product tab and verify:<\/p>\n<ul>\n<li>Patient first and last name and unique identifier number<\/li>\n<li>Type of blood product and ABO blood grouping<\/li>\n<li>11-digit serial number<\/li>\n<li>Product expiry date and time<\/li>\n<li>Special requirements (e.g., irradiated)<\/li>\n<li>G &amp; S expiry date<\/li>\n<\/ul>\n<\/td>\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">All verification numbers\/information must match exactly.<\/p>\n<p>Must be completed by two trained staff members competent in blood transfusion administration process as set out by the agency.<\/p>\n<p>Confirm the patient blood type and Rh are compatible with the donor blood type and Rh.<\/p>\n<p>If there are any discrepancies, stop the process and contact the TMS for resolution and direction. Do not proceed.<\/p>\n<p>Ensure the blood product matches the physician&#8217;s orders (red blood cells or platelets).<\/p>\n<figure id=\"attachment_6516\" aria-describedby=\"caption-attachment-6516\" style=\"width: 152px\" class=\"wp-caption aligncenter\"><a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-033.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-6516\" src=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-033-300x199.jpg\" alt=\"TMS record\" width=\"152\" height=\"101\" srcset=\"https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-033-300x199.jpg 300w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-033-1024x678.jpg 1024w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-033-65x43.jpg 65w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-033-225x149.jpg 225w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-033-350x232.jpg 350w\" sizes=\"auto, (max-width: 152px) 100vw, 152px\" \/><\/a><figcaption id=\"caption-attachment-6516\" class=\"wp-caption-text\">TMS record<\/figcaption><\/figure>\n<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">8 Administer pre-medications as ordered.<\/td>\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Medications must be administered through an IV infusion set, and the IV site cleared with 0.9% NS.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">9. Final verification (must be completed by the same two staff members as noted in Step 7).<\/p>\n<p>Compare the patient&#8217;s first and last name and unique identifier number using all of the following:<\/p>\n<ul>\n<li>Patient identification band or equivalent ID process as approved by the TMS (Ask the patient to spell first and last name and state date of birth.)<\/li>\n<li>TMS documentation<\/li>\n<li>Compatibility tag and label attached to blood product<\/li>\n<\/ul>\n<p>Only after recipient identification and product check is confirmed, invert product 5 to\u00a010 times and insert spike of the blood administration set into the blood product container.<\/td>\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">All verification numbers must match exactly. If there are any discrepancies, stop the process and contact the TMS for resolution and direction. Do not proceed.<\/p>\n<figure id=\"attachment_6517\" aria-describedby=\"caption-attachment-6517\" style=\"width: 184px\" class=\"wp-caption aligncenter\"><a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-032.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-6517\" src=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-032-300x208.jpg\" alt=\"Identify patient\" width=\"184\" height=\"128\" srcset=\"https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-032-300x208.jpg 300w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-032-65x45.jpg 65w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-032-225x156.jpg 225w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-032-350x242.jpg 350w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-032.jpg 974w\" sizes=\"auto, (max-width: 184px) 100vw, 184px\" \/><\/a><figcaption id=\"caption-attachment-6517\" class=\"wp-caption-text\">Identify patient<\/figcaption><\/figure>\n<p>Patients who are alert and oriented should be asked to:<\/p>\n<ul>\n<li>Spell first and last name<\/li>\n<li>State their date of birth<\/li>\n<\/ul>\n<p>All identifying information attached to the blood bag must remain attached at least until completion of transfusion.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">10. Perform hand hygiene. Prime the blood product administration set:<\/p>\n<ul>\n<li>Close clamp. Completely cover the filter with product.<\/li>\n<li>A straight blood administration set is used for all transfusions.<\/li>\n<li>A Y-type blood administration set should only be considered in clinical situations where additional fluid volume may be required.<\/li>\n<\/ul>\n<\/td>\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Do not remove the product from the presence of the patient; prime at bedside. If product is removed from bedside, the final verification process must be completed again.<\/p>\n<figure id=\"attachment_5773\" aria-describedby=\"caption-attachment-5773\" style=\"width: 155px\" class=\"wp-caption aligncenter\"><a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_1178-e1442761410159.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-5773\" src=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_1178-e1442761410159-199x300.jpg\" alt=\"Prime blood tubing\" width=\"155\" height=\"234\" srcset=\"https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_1178-e1442761410159-199x300.jpg 199w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_1178-e1442761410159-678x1024.jpg 678w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_1178-e1442761410159-65x98.jpg 65w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_1178-e1442761410159-225x340.jpg 225w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_1178-e1442761410159-350x528.jpg 350w\" sizes=\"auto, (max-width: 155px) 100vw, 155px\" \/><\/a><figcaption id=\"caption-attachment-5773\" class=\"wp-caption-text\">Prime blood tubing<\/figcaption><\/figure>\n<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">11. Initiate transfusion:<\/p>\n<ul>\n<li>Obtain vital signs immediately prior to transfusion, then 15 minutes after initiation, then every hour until transfusion is complete.<\/li>\n<li>Maintaining asepsis, disconnect the NS infusion and connect blood administration set and start transfusion.<\/li>\n<li>Advise patient on the signs and symptoms of transfusion reaction and what and when to report.<\/li>\n<\/ul>\n<\/td>\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Adults: Initiate red cells slowly (25 ml in the first 15 minutes). For all other blood transfusions, refer to the blood and product sheet as per your agency policy.<\/p>\n<p>Some agencies use an EID to administer blood transfusions. Always check agency policy prior to transfusion.<\/p>\n<p>For each and every unit:<\/p>\n<ul>\n<li>Remain with the patient for the first 5 minutes and assess for clinical signs of transfusion reaction.<\/li>\n<li>Complete transfusion within 4 hours of removal from the blood bank.<\/li>\n<\/ul>\n<p>Most transfusion reactions occur within first 15 minutes of a transfusion.\u00a0Infusing small amounts of blood component initially minimizes volume of blood to which patient is exposed, thereby minimizing severity of reaction.<\/p>\n<figure id=\"attachment_5792\" aria-describedby=\"caption-attachment-5792\" style=\"width: 190px\" class=\"wp-caption aligncenter\"><a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_1200-e1442761865948.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-5792\" src=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_1200-e1442761865948-300x199.jpg\" alt=\"Infusion of packed RBC\" width=\"190\" height=\"126\" srcset=\"https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_1200-e1442761865948-300x199.jpg 300w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_1200-e1442761865948-1024x678.jpg 1024w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_1200-e1442761865948-65x43.jpg 65w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_1200-e1442761865948-225x149.jpg 225w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_1200-e1442761865948-350x232.jpg 350w\" sizes=\"auto, (max-width: 190px) 100vw, 190px\" \/><\/a><figcaption id=\"caption-attachment-5792\" class=\"wp-caption-text\">Infusion of packed red blood cells<\/figcaption><\/figure>\n<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">12. Monitor:<\/p>\n<ul>\n<li>Assess and observe for clinical signs and symptoms of reactions up to 24 hours post-transfusion.<\/li>\n<li>Complete all appropriate clinical documentation.<\/li>\n<\/ul>\n<\/td>\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Vital signs must be monitored:<\/p>\n<ul>\n<li>Immediately prior to infusion<\/li>\n<li>Within 10 to\u00a015 minutes<\/li>\n<li>Every hour until transfusion is complete<\/li>\n<\/ul>\n<figure id=\"attachment_6464\" aria-describedby=\"caption-attachment-6464\" style=\"width: 120px\" class=\"wp-caption aligncenter\"><a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-107.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-6464\" src=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-107-209x300.jpg\" alt=\"vital signs\" width=\"120\" height=\"173\" srcset=\"https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-107-209x300.jpg 209w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-107.jpg 713w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-107-65x93.jpg 65w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-107-225x323.jpg 225w, https:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-107-350x503.jpg 350w\" sizes=\"auto, (max-width: 120px) 100vw, 120px\" \/><\/a><figcaption id=\"caption-attachment-6464\" class=\"wp-caption-text\">Vital signs<\/figcaption><\/figure>\n<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">13. In the event of a transfusion reaction, stop the infusion.<\/td>\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">\n<ul>\n<li>Manage transfusion reactions as per protocol.<\/li>\n<li>Complete required transfusion reaction form.<\/li>\n<li>Return remaining blood to blood bank for further investigation.<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">14. For additional units, repeat steps 6 to 12.<\/td>\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Follow the same process to ensure patient safety.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">15. Flush administration set with maximum of 50 ml of normal saline and re-establish IV or SL as per physician orders.<\/td>\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Flushing displaces any blood or blood product from the administration set. It is not necessary to flush between units of the same blood product.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">16. Discard waste in biohazard waste container.<\/td>\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">This prevents the spread of biohazard waste.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"3\">17. Complete all documentation as required by agency.<\/td>\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"2\">Documentation may include:<\/p>\n<ul>\n<li>Transfusion record form<\/li>\n<li>All vital signs and reactions<\/li>\n<li>Any significant findings, initiation and termination of transfusion<\/li>\n<li>Record of transfusion on the in-and-out sheet<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 250px;\" colspan=\"5\">Data source: Alberta Health Services, 2015a, 2015b; Perry et al., 2014; Vancouver Coastal Health, 2008<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<div class=\"textbox textbox--exercises\">\n<header class=\"textbox__header\">\n<p class=\"textbox__title\">Critical Thinking Exercises<\/p>\n<\/header>\n<div class=\"textbox__content\">\n<ol>\n<li>How many units of blood can be transfused through one blood administration set?<\/li>\n<li>What are the steps to managing a blood transfusion reaction?<\/li>\n<\/ol>\n<\/div>\n<\/div>\n","protected":false},"author":5,"menu_order":7,"template":"","meta":{"pb_show_title":"on","pb_short_title":"","pb_subtitle":"","pb_authors":[],"pb_section_license":""},"chapter-type":[],"contributor":[],"license":[],"class_list":["post-3697","chapter","type-chapter","status-publish","hentry"],"part":3534,"_links":{"self":[{"href":"https:\/\/opentextbc.ca\/clinicalskills\/wp-json\/pressbooks\/v2\/chapters\/3697","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/opentextbc.ca\/clinicalskills\/wp-json\/pressbooks\/v2\/chapters"}],"about":[{"href":"https:\/\/opentextbc.ca\/clinicalskills\/wp-json\/wp\/v2\/types\/chapter"}],"author":[{"embeddable":true,"href":"https:\/\/opentextbc.ca\/clinicalskills\/wp-json\/wp\/v2\/users\/5"}],"version-history":[{"count":30,"href":"https:\/\/opentextbc.ca\/clinicalskills\/wp-json\/pressbooks\/v2\/chapters\/3697\/revisions"}],"predecessor-version":[{"id":10169,"href":"https:\/\/opentextbc.ca\/clinicalskills\/wp-json\/pressbooks\/v2\/chapters\/3697\/revisions\/10169"}],"part":[{"href":"https:\/\/opentextbc.ca\/clinicalskills\/wp-json\/pressbooks\/v2\/parts\/3534"}],"metadata":[{"href":"https:\/\/opentextbc.ca\/clinicalskills\/wp-json\/pressbooks\/v2\/chapters\/3697\/metadata\/"}],"wp:attachment":[{"href":"https:\/\/opentextbc.ca\/clinicalskills\/wp-json\/wp\/v2\/media?parent=3697"}],"wp:term":[{"taxonomy":"chapter-type","embeddable":true,"href":"https:\/\/opentextbc.ca\/clinicalskills\/wp-json\/pressbooks\/v2\/chapter-type?post=3697"},{"taxonomy":"contributor","embeddable":true,"href":"https:\/\/opentextbc.ca\/clinicalskills\/wp-json\/wp\/v2\/contributor?post=3697"},{"taxonomy":"license","embeddable":true,"href":"https:\/\/opentextbc.ca\/clinicalskills\/wp-json\/wp\/v2\/license?post=3697"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}